nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.0268	0.0645	CbGeAlD
Oxazepam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0232	0.0559	CbGeAlD
Oxazepam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.0224	0.0538	CbGeAlD
Oxazepam—GABRQ—nerve—amyotrophic lateral sclerosis	0.0209	0.0503	CbGeAlD
Oxazepam—GABRR3—nerve—amyotrophic lateral sclerosis	0.0209	0.0503	CbGeAlD
Oxazepam—GABRR2—nerve—amyotrophic lateral sclerosis	0.0181	0.0436	CbGeAlD
Oxazepam—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0888	CcSEcCtD
Oxazepam—GABRR1—nerve—amyotrophic lateral sclerosis	0.0174	0.042	CbGeAlD
Oxazepam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0701	CcSEcCtD
Oxazepam—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0127	0.064	CcSEcCtD
Oxazepam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0569	CcSEcCtD
Oxazepam—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0109	0.055	CcSEcCtD
Oxazepam—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.0109	0.0261	CbGeAlD
Oxazepam—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0512	CcSEcCtD
Oxazepam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00953	0.0481	CcSEcCtD
Oxazepam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00896	0.0452	CcSEcCtD
Oxazepam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.008	0.0192	CbGeAlD
Oxazepam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00788	0.906	CrCbGaD
Oxazepam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00731	0.0176	CbGeAlD
Oxazepam—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00716	0.0361	CcSEcCtD
Oxazepam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00706	0.017	CbGeAlD
Oxazepam—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00686	0.0346	CcSEcCtD
Oxazepam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00656	0.0331	CcSEcCtD
Oxazepam—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00623	0.015	CbGeAlD
Oxazepam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00538	0.0271	CcSEcCtD
Oxazepam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00528	0.0266	CcSEcCtD
Oxazepam—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00516	0.026	CcSEcCtD
Oxazepam—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00515	0.026	CcSEcCtD
Oxazepam—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0259	CcSEcCtD
Oxazepam—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00505	0.0255	CcSEcCtD
Oxazepam—GABRQ—nervous system—amyotrophic lateral sclerosis	0.0047	0.0113	CbGeAlD
Oxazepam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.0047	0.0113	CbGeAlD
Oxazepam—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0236	CcSEcCtD
Oxazepam—Shock—Riluzole—amyotrophic lateral sclerosis	0.00461	0.0233	CcSEcCtD
Oxazepam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00458	0.011	CbGeAlD
Oxazepam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00454	0.0109	CbGeAlD
Oxazepam—GABRQ—central nervous system—amyotrophic lateral sclerosis	0.00453	0.0109	CbGeAlD
Oxazepam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0221	CcSEcCtD
Oxazepam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00437	0.0105	CbGeAlD
Oxazepam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.00424	0.0102	CbGeAlD
Oxazepam—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00421	0.0212	CcSEcCtD
Oxazepam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00419	0.0101	CbGeAlD
Oxazepam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00417	0.021	CcSEcCtD
Oxazepam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00412	0.0099	CbGeAlD
Oxazepam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00408	0.0098	CbGeAlD
Oxazepam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00405	0.00974	CbGeAlD
Oxazepam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00396	0.00953	CbGeAlD
Oxazepam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00392	0.00944	CbGeAlD
Oxazepam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.00389	0.00937	CbGeAlD
Oxazepam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00384	0.00923	CbGeAlD
Oxazepam—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0193	CcSEcCtD
Oxazepam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.00378	0.00909	CbGeAlD
Oxazepam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00378	0.00908	CbGeAlD
Oxazepam—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0037	0.0187	CcSEcCtD
Oxazepam—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0037	0.0187	CcSEcCtD
Oxazepam—GABRQ—brain—amyotrophic lateral sclerosis	0.00359	0.00864	CbGeAlD
Oxazepam—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00345	0.0174	CcSEcCtD
Oxazepam—GABRD—nervous system—amyotrophic lateral sclerosis	0.00341	0.0082	CbGeAlD
Oxazepam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00328	0.0079	CbGeAlD
Oxazepam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00328	0.00789	CbGeAlD
Oxazepam—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00326	0.00785	CbGeAlD
Oxazepam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00321	0.00772	CbGeAlD
Oxazepam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.0032	0.00769	CbGeAlD
Oxazepam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.0032	0.00769	CbGeAlD
Oxazepam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00318	0.00765	CbGeAlD
Oxazepam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00317	0.00761	CbGeAlD
Oxazepam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00316	0.0076	CbGeAlD
Oxazepam—GABRG3—brain—amyotrophic lateral sclerosis	0.00315	0.00757	CbGeAlD
Oxazepam—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.00314	0.00756	CbGeAlD
Oxazepam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0031	0.0156	CcSEcCtD
Oxazepam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00309	0.00743	CbGeAlD
Oxazepam—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.00307	0.00739	CbGeAlD
Oxazepam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00306	0.00737	CbGeAlD
Oxazepam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00305	0.00733	CbGeAlD
Oxazepam—GABRR1—brain—amyotrophic lateral sclerosis	0.003	0.00721	CbGeAlD
Oxazepam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00299	0.0072	CbGeAlD
Oxazepam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0149	CcSEcCtD
Oxazepam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0149	CcSEcCtD
Oxazepam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00295	0.00709	CbGeAlD
Oxazepam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00294	0.0148	CcSEcCtD
Oxazepam—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00287	0.00691	CbGeAlD
Oxazepam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00285	0.00686	CbGeAlD
Oxazepam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00285	0.00686	CbGeAlD
Oxazepam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00284	0.00682	CbGeAlD
Oxazepam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00282	0.00679	CbGeAlD
Oxazepam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00278	0.014	CcSEcCtD
Oxazepam—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00276	0.00665	CbGeAlD
Oxazepam—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.0027	0.0065	CbGeAlD
Oxazepam—GABRD—brain—amyotrophic lateral sclerosis	0.00261	0.00627	CbGeAlD
Oxazepam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00252	0.00605	CbGeAlD
Oxazepam—GABRG1—brain—amyotrophic lateral sclerosis	0.00251	0.00603	CbGeAlD
Oxazepam—GABRA6—brain—amyotrophic lateral sclerosis	0.00249	0.006	CbGeAlD
Oxazepam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00246	0.00591	CbGeAlD
Oxazepam—GABRB1—brain—amyotrophic lateral sclerosis	0.00243	0.00585	CbGeAlD
Oxazepam—GABRA5—brain—amyotrophic lateral sclerosis	0.00242	0.00582	CbGeAlD
Oxazepam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.0024	0.00578	CbGeAlD
Oxazepam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.0024	0.00578	CbGeAlD
Oxazepam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00231	0.00556	CbGeAlD
Oxazepam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00231	0.00556	CbGeAlD
Oxazepam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00226	0.00544	CbGeAlD
Oxazepam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00226	0.00544	CbGeAlD
Oxazepam—GABRA3—brain—amyotrophic lateral sclerosis	0.00225	0.00542	CbGeAlD
Oxazepam—GABRA4—brain—amyotrophic lateral sclerosis	0.00219	0.00528	CbGeAlD
Oxazepam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00219	0.00528	CbGeAlD
Oxazepam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00219	0.00527	CbGeAlD
Oxazepam—GABRE—nervous system—amyotrophic lateral sclerosis	0.00218	0.00523	CbGeAlD
Oxazepam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00212	0.0051	CbGeAlD
Oxazepam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00211	0.00508	CbGeAlD
Oxazepam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.0021	0.00504	CbGeAlD
Oxazepam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00207	0.00497	CbGeAlD
Oxazepam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00204	0.00491	CbGeAlD
Oxazepam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.002	0.0048	CbGeAlD
Oxazepam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00184	0.00444	CbGeAlD
Oxazepam—GABRB2—brain—amyotrophic lateral sclerosis	0.00184	0.00442	CbGeAlD
Oxazepam—GABRG2—brain—amyotrophic lateral sclerosis	0.00184	0.00442	CbGeAlD
Oxazepam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00178	0.00427	CbGeAlD
Oxazepam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00174	0.00418	CbGeAlD
Oxazepam—GABRA2—brain—amyotrophic lateral sclerosis	0.00168	0.00403	CbGeAlD
Oxazepam—GABRE—brain—amyotrophic lateral sclerosis	0.00166	0.004	CbGeAlD
Oxazepam—GABRA1—brain—amyotrophic lateral sclerosis	0.00162	0.0039	CbGeAlD
Oxazepam—GABRB3—brain—amyotrophic lateral sclerosis	0.00141	0.00339	CbGeAlD
Oxazepam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000944	0.00227	CbGeAlD
Oxazepam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000909	0.00219	CbGeAlD
Oxazepam—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.00082	0.0942	CrCbGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000704	0.00187	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000703	0.00186	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000703	0.00186	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0007	0.00185	CbGpPWpGaD
Oxazepam—UGT1A9—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000699	0.00185	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000696	0.00184	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000696	0.00184	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000692	0.00183	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000692	0.00183	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00069	0.00183	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000688	0.00182	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000687	0.00182	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000679	0.0018	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000677	0.00179	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000676	0.00179	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000675	0.00179	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000671	0.00178	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000668	0.00177	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000664	0.00176	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000664	0.00176	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000659	0.00175	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000656	0.00174	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000655	0.00174	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000655	0.00174	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000655	0.00173	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000655	0.00173	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000652	0.00173	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000648	0.00172	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000647	0.00171	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000647	0.00171	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000645	0.00171	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000644	0.00171	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000643	0.0017	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000642	0.0017	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000641	0.0017	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000636	0.00169	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000636	0.00169	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000635	0.00168	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000629	0.00167	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000626	0.00166	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000624	0.00165	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000618	0.00164	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000617	0.00164	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000617	0.00164	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000617	0.00163	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—DAO—amyotrophic lateral sclerosis	0.000612	0.00162	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000607	0.00161	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000599	0.00159	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000599	0.00159	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000596	0.00158	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000596	0.00158	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000593	0.00157	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000591	0.00157	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000591	0.00157	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000584	0.00155	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000582	0.00154	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00058	0.00154	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000576	0.00153	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000576	0.00153	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000575	0.00152	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000575	0.00152	CbGpPWpGaD
Oxazepam—UGT2B7—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000574	0.00152	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000566	0.0015	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000564	0.0015	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000564	0.0015	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000564	0.00149	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000563	0.00149	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000557	0.00148	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000556	0.00147	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000556	0.00147	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000555	0.00147	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000555	0.00147	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000554	0.00147	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000551	0.00146	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000551	0.00146	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00055	0.00146	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000544	0.00144	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000541	0.00143	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000541	0.00143	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000541	0.00143	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00054	0.00143	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00054	0.00143	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000531	0.00141	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000527	0.0014	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000523	0.00139	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000512	0.00136	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000509	0.00135	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000504	0.00133	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000503	0.00133	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000497	0.00132	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000494	0.00131	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000491	0.0013	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000484	0.00128	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000482	0.00128	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000481	0.00127	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000481	0.00127	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—DAO—amyotrophic lateral sclerosis	0.000473	0.00125	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000473	0.00125	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000473	0.00125	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000466	0.00124	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000464	0.00123	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000464	0.00123	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000459	0.00122	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000459	0.00122	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000459	0.00122	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000459	0.00122	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000444	0.00118	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000438	0.00116	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000429	0.00114	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSR—amyotrophic lateral sclerosis	0.000428	0.00114	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000421	0.00112	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000414	0.0011	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000409	0.00108	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000409	0.00108	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000409	0.00108	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000409	0.00108	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000404	0.00107	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000389	0.00103	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000386	0.00102	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000386	0.00102	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000386	0.00102	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000378	0.001	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000378	0.001	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000374	0.000991	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000372	0.000986	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000372	0.000986	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000363	0.000963	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000359	0.00095	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000357	0.000945	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000353	0.000935	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000352	0.000933	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000352	0.000933	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000352	0.000932	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000351	0.000929	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000348	0.000923	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000348	0.000921	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000348	0.000921	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000344	0.000912	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000342	0.000906	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000339	0.000899	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000337	0.000892	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000332	0.000879	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSR—amyotrophic lateral sclerosis	0.000331	0.000877	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000328	0.000869	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000318	0.000843	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000318	0.000843	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000314	0.000832	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000314	0.000831	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000314	0.000831	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00031	0.000821	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000309	0.000819	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000309	0.000819	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000308	0.000817	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000303	0.000804	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000303	0.000804	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000299	0.000792	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000298	0.00079	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000298	0.00079	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000296	0.000785	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000296	0.000785	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000292	0.000775	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000291	0.000771	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000291	0.000771	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000287	0.00076	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000283	0.000751	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000279	0.000739	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000275	0.00073	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000272	0.00072	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00027	0.000717	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000267	0.000706	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000266	0.000704	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000264	0.0007	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000264	0.000699	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000264	0.000699	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000259	0.000687	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000258	0.000685	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000254	0.000674	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000254	0.000674	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000251	0.000664	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000249	0.000659	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000245	0.00065	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000242	0.00064	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000241	0.000639	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000227	0.000601	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000227	0.0006	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000224	0.000594	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000211	0.00056	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000211	0.000559	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000195	0.000517	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000195	0.000516	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000191	0.000505	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000191	0.000505	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000191	0.000505	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000189	0.000501	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000174	0.000462	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000174	0.00046	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000172	0.000455	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000165	0.000438	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000162	0.000429	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00016	0.000425	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000159	0.00042	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000152	0.000404	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000146	0.000387	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000144	0.000383	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000144	0.000383	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—APOE—amyotrophic lateral sclerosis	0.000143	0.000379	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000138	0.000365	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000134	0.000356	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000133	0.000353	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00013	0.000345	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000119	0.000315	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000116	0.000306	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000114	0.000302	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—APOE—amyotrophic lateral sclerosis	0.00011	0.000293	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000109	0.00029	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000104	0.000277	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.79e-05	0.00026	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	9.64e-05	0.000255	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	8.86e-05	0.000235	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	8.86e-05	0.000235	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.61e-05	0.000228	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.14e-05	0.000216	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.1e-05	0.000215	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	7.91e-05	0.00021	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.91e-05	0.00021	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.57e-05	0.000201	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.53e-05	0.0002	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.08e-05	0.000188	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	7e-05	0.000185	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	6.51e-05	0.000173	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.43e-05	0.00017	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	6.41e-05	0.00017	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.88e-05	0.000156	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.41e-05	0.000143	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	5.29e-05	0.00014	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.86e-05	0.000129	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.48e-05	0.000119	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.46e-05	0.000118	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	4.45e-05	0.000118	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.25e-05	0.000113	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.91e-05	0.000104	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.68e-05	9.75e-05	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.62e-05	9.61e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	3.22e-05	8.52e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.05e-05	8.08e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.2e-05	5.84e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.98e-05	5.24e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.82e-05	4.82e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.5e-05	3.96e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	2.71e-05	CbGpPWpGaD
